Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
April 26, 2016
Patent Application Number
12304121
Date Filed
June 12, 2007
Patent Citations Received
Patent Primary Examiner
Patent abstract
Disclosed herein are an N-terminal modified PEG-TRAIL conjugate and a preparation method and use thereof. The PEG-TAIL conjugate has pharmaceutical activity identical or similar to that of native TRAIL (TNF-related apoptosis-inducing ligand) with extended in vivo half-life and enhanced stability. Compared to native TRAIL, the PEG-TAIL conjugate exhibits high solubility and solution stability, with highly improved pharmacokinetic profiles. Thus, the PEG-TAIL conjugate may be very useful for preventing and treating proliferative diseases and autoimmune diseases.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
